Long-term clinical evaluation represents key advancement following successful first-in-human studyRUTHERFORD, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...

The Swiss biotech company Roche on Monday announced plans for a $550 million expansion of its Indianapolis diagnostics and ...

Dr Ray O’Connor continues his look at the latest clinical articles on the importance of lifestyle advice in doctor-patient ...

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry.

Glucotrack (Nasdaq:GCTK) announced today that it received a hospital's ethical approval to study its continuous blood glucose ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, is proud to announce the publication of its ...

Find out more about ICT and its influence on our lives. Enter now and don't miss it on our blog. Read now in our blog.

The Patent Trial and Appeal Board was ordered to review a claim by a UC Berkeley team that gene-editing technology originated in their studies and not with the Broad Institute of Harvard and MIT. Also ...

This guide covers key tools and communication features to make the most of technology in managing your health.

Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.